TransMedics(TMDX) - 2025 Q4 - Earnings Call Presentation

TransMedics Q4 2025 Performance Highlights February 24, 2026 2 TMDX Q4 2025 Performance – Key Highlights Product Revenue $100.4M 33.9% Y/Y Growth 14.5% Q/Q Growth 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements address various matters, including, among other things, future results and events, including financial guidance and projected estimates, and other statements that are predictive in nature. Investors are cau ...